260 Institutional Ownership
CENTESSA PHARMACEUTICALS-ADR
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro. The overall institutional consensus preview remains public.
Compare plans.
Cross-institution intelligence
Institutional Research
Each institution is compared with its own prior filing, then the latest institution-level directions are compared for breadth.
Latest filing
Jul 8, 2026
Public consensus preview
Reduction leaning
30/100 institutional research score
1 tracked institution
Latest filing Jul 8, 2026
1 reducing across 1 comparable institution.
Accumulating0
Unchanged0
Reducing1
Exited0
The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.
Price context
52-week position is market context and does not change the institutional consensus score.
52-week range data is not available for this security yet.
Tracked institutions
Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.
Fidelity / FMR
Jul 8, 2026 filed
Beneficial ownership filing history
Showing 3 of 3 parsed filing(s)| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Fidelity / FMR CIK0000315066 | Jun 30, 2026 observed Jul 8, 2026 filed · 8d Schedule 13G amendment | Reported reduction | 1.8K -6.8M | 12.00% 0.00 pts | |||
| Fidelity / FMR CIK0000315066 | Mar 31, 2026 observed May 6, 2026 filed · 36d Schedule 13G amendment | Reported reduction | 6.8M -4.2M | 12.00% -0.20 pts | |||
| Fidelity / FMR CIK0000315066 | Jan 30, 2026 observed Feb 6, 2026 filed · 7d Schedule 13G amendment | Earliest Schedule 13G amendment found | 11.0M | 12.20% |
Explore more institutional activity
Related research
Crawlable links to other securities with similar institutional consensus or recent multi-institution accumulation.